为减少伤害而开具大麻处方。
Prescribing cannabis for harm reduction.
机构信息
PainExhibit,com, 9008 El Cajon Way, #4, Sacramento, CA, 95826, USA.
出版信息
Harm Reduct J. 2012 Jan 1;9:1. doi: 10.1186/1477-7517-9-1.
Abstract
Neuropathic pain affects between 5% and 10% of the US population and can be refractory to treatment. Opioids may be recommended as a second-line pharmacotherapy but have risks including overdose and death. Cannabis has been shown to be effective for treating nerve pain without the risk of fatal poisoning. The author suggests that physicians who treat neuropathic pain with opioids should evaluate their patients for a trial of cannabis and prescribe it when appropriate prior to using opioids. This harm reduction strategy may reduce the morbidity and mortality rates associated with prescription pain medications.
摘要
神经性疼痛影响美国人口的 5%至 10%，且可能对治疗有抗药性。阿片类药物可能被推荐作为二线药物治疗，但存在包括过量和死亡在内的风险。大麻已被证明对治疗神经痛有效，且没有致命中毒的风险。作者建议，用阿片类药物治疗神经性疼痛的医生应该评估他们的患者是否适合试用大麻，并在使用阿片类药物之前酌情开出大麻处方。这种减少伤害的策略可能会降低与处方止痛药相关的发病率和死亡率。
相似文献
1
Prescribing cannabis for harm reduction.
Harm Reduct J. 2012 Jan 1;9:1. doi: 10.1186/1477-7517-9-1.
2
Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
J Opioid Manag. 2021 Jan-Feb;17(1):19-38. doi: 10.5055/jom.2021.0611.
3
Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report.
Cannabis Cannabinoid Res. 2017 Jun 1;2(1):160-166. doi: 10.1089/can.2017.0012. eCollection 2017.
4
[Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
Encephale. 2016 Dec;42(6):511-516. doi: 10.1016/j.encep.2016.05.010. Epub 2016 Oct 21.
5
Rationale for cannabis-based interventions in the opioid overdose crisis.
Harm Reduct J. 2017 Aug 18;14(1):58. doi: 10.1186/s12954-017-0183-9.
6
Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Pain Physician. 2017 Feb;20(2S):S3-S92.
7
Potentially Inappropriate Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011-2015.
J Gen Intern Med. 2018 Sep;33(9):1512-1519. doi: 10.1007/s11606-018-4532-5. Epub 2018 Jun 14.
8
Opioids Use and Abuse: Prescription Practice, Attitude, and Beliefs among Doctors of Karachi.
Cureus. 2019 Jul 27;11(7):e5253. doi: 10.7759/cureus.5253.
9
Are Physicians Safely Prescribing Opioids for Chronic Noncancer Pain? A Systematic Review of Current Evidence.
Pain Pract. 2016 Mar;16(3):370-83. doi: 10.1111/papr.12289. Epub 2015 Apr 10.
10
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
引用本文的文献
1
Cannabis donation as a harm reduction strategy: a case study.
Harm Reduct J. 2024 Mar 6;21(1):58. doi: 10.1186/s12954-024-00974-3.
2
A Pragmatic, Person-Centered View of Cannabis in the United States: Pursuing Care That Transcends Beliefs.
Subst Abus. 2023 Oct;44(4):337-347. doi: 10.1177/08897077231202836. Epub 2023 Oct 30.
3
To Treat or Not to Treat? Polish Physicians' Opinions about the Clinical Aspects of Cannabinoids-An Online Survey.
J Clin Med. 2022 Jan 1;11(1):236. doi: 10.3390/jcm11010236.
4
Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample.
Harm Reduct J. 2021 Jul 10;18(1):72. doi: 10.1186/s12954-021-00520-5.
5
assessment of the cytotoxic, genotoxic and oxidative stress effects of the synthetic cannabinoid JWH-018 in human SH-SY5Y neuronal cells.
Toxicol Res (Camb). 2020 Nov 4;9(6):734-740. doi: 10.1093/toxres/tfaa078. eCollection 2020 Dec.
6
Opioid Misuse and the Availability of Medical Marijuana Through Dispensaries.
J Stud Alcohol Drugs. 2020 Jul;81(4):489-496. doi: 10.15288/jsad.2020.81.489.
7
Cannabidiol in Anxiety and Sleep: A Large Case Series.
Perm J. 2019;23:18-041. doi: 10.7812/TPP/18-041.
8
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.
J Headache Pain. 2018 May 24;19(1):37. doi: 10.1186/s10194-018-0862-2.
9
A user's guide to cannabinoid therapies in oncology.
Curr Oncol. 2016 Dec;23(6):398-406. doi: 10.3747/co.23.3487. Epub 2016 Dec 21.
10
Medical marijuana programs - Why might they matter for public health and why should we better understand their impacts?
Prev Med Rep. 2015 Jan 2;2:53-6. doi: 10.1016/j.pmedr.2014.12.006. eCollection 2015.
本文引用的文献
1
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Br J Pharmacol. 2011 Aug;163(7):1344-64. doi: 10.1111/j.1476-5381.2011.01238.x.
2
Cannabis and its derivatives: review of medical use.
J Am Board Fam Med. 2011 Jul-Aug;24(4):452-62. doi: 10.3122/jabfm.2011.04.100280.
3
Evidence-based medicine: what is the evidence that it has made a difference?
Palliat Med. 2011 Jul;25(5):394-7. doi: 10.1177/0269216310394707.
4
Cannabis with high cannabidiol content is associated with fewer psychotic experiences.
Schizophr Res. 2011 Aug;130(1-3):216-21. doi: 10.1016/j.schres.2011.04.017. Epub 2011 May 17.
5
Cannabinoids for pain management.
Adv Psychosom Med. 2011;30:125-138. doi: 10.1159/000324070. Epub 2011 Apr 19.
6
Cannabis in palliative medicine: improving care and reducing opioid-related morbidity.
Am J Hosp Palliat Care. 2011 Aug;28(5):297-303. doi: 10.1177/1049909111402318. Epub 2011 Mar 28.
7
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.
Br J Clin Pharmacol. 2011 Nov;72(5):735-44. doi: 10.1111/j.1365-2125.2011.03970.x.
8
Recent advances in pharmacological treatment of neuropathic pain.
F1000 Med Rep. 2010 Jul 14;2:52. doi: 10.3410/M2-52.
9
Using cannabinoids in pain and palliative care.
Int J Palliat Nurs. 2010 Oct;16(10):481-5. doi: 10.12968/ijpn.2010.16.10.79211.
10
Endogenous opiates and behavior: 2009.
Peptides. 2010 Dec;31(12):2325-59. doi: 10.1016/j.peptides.2010.09.016. Epub 2010 Sep 25.
Zotero 插件